Rechercher des projets européens

Plus de 40 projets européens trouvés

Recherche sur 125080 projets européens

 TERMINÉ 

Targeting perivascular myofibroblast progenitors to treat cardiac fibrosis and heart failure in chronic kidney disease (CureCKDHeart)

Date du début: 1 mai 2016, Date de fin: 30 avr. 2021,

Chronic kidney disease (CKD) is a growing public health problem with a massively increased cardiovascular mortality. Patients with advanced CKD mostly die from sudden cardiac death and recurrent heart failure due to premature cardiac aging with hypertrophy, fibrosis, and capillary rarefaction. I have recently identified the long sought key cardiac myofibroblast progenitor population, an emerging b ...
Voir le projet

 1

 TERMINÉ 

Connecting Patients and Carers using wearable sensor technology (NIGHTINGALE)

Date du début: 1 nov. 2016, Date de fin: 31 oct. 2020,

Safest, reliable, individualised care of patients at-risk of deterioration needs patients themselves to play an active role in their care whenever possible: late detection or escalation of deterioration causes avoidable harms, and deaths. In this project we will challenge industry to develop robust monitoring and communications systems that connect patients, carers and health professionals, provid ...
Voir le projet

 5

 TERMINÉ 

Digital Hybrid Breast PET/MRI for Enhanced Diagnosis of Breast Cancer (HYPMED)

Date du début: 1 janv. 2016, Date de fin: 31 déc. 2019,

Breast cancer represents a leading cause of cancer death in women and a major socio-economic issue. With currently available methods, early diagnosis frequently fails. Moreover, beyond mere detection, there is an ever-increasing need for improved non-invasive characterisation of cancer. Targeted therapies require an in-depth analysis of cancer to select and guide appropriate treatment. Both, PET a ...
Voir le projet

 10

 TERMINÉ 

Renal Molecular Pathologist network

Date du début: 1 sept. 2016, Date de fin: 31 août 2019,

Rationale and background The prevention and care of chronic diseases are among the priorities of the EU's current health strategy. Chronic kidney disease (CKD), one of the most common chronic degenerative diseases, is often accompanied by a high mortality and morbidity, and has a high socio-economic impact. Objectives•Strengthen the cooperation among Universities in order to boost innovation and e ...
Voir le projet

 7

 TERMINÉ 

Systematic Models for Biological Systems Engineering Training Network (SyMBioSys)

Date du début: 1 sept. 2015, Date de fin: 31 août 2019,

Mathematical, computational models are central in biomedical and biological systems engineering; models enable (i) mechanistically justifying experimental results via current knowledge and (ii) generating new testable hypotheses or novel intervention methods. SyMBioSys is a joint academic/industrial training initiative supporting the convergence of engineering, biological and computational science ...
Voir le projet

 11

 TERMINÉ 

THALEA II - Telemonitoring and Telemedicine for Hospitals Assisted by ICT for Life saving co-morbid patients in Europe As part of a Patient personalised care program of the EU (THALEA II)

Date du début: 1 juin 2016, Date de fin: 31 mai 2019,

Public procurement of innovative solutions (PPI) shortens the route to market, sets free the potential of early adopters to implement an innovation and enables public procurers to efficiently answer market demands of innovative products.THALEA II is the first follow-up PPI in healthcare for Intensive Care Units (ICU). It will bring an innovative product to the European healthcare market aiming to ...
Voir le projet

 6

 TERMINÉ 

Real time therapy planning for Thermal based therapy modalities in oncology care. (AdapTT)

Date du début: 1 janv. 2015, Date de fin: 31 déc. 2018,

AdapTT will unlock the potential for development of a real time adaptive therapy planning tool for thermal treatment in prostate oncology. Highly specialized and cost effective state-of-the-art scientific solutions can only be developed when complimentary partners of different sectors work synergistically. The intersectoral nature of the European Industrial Doctorates (EID) framework, between indu ...
Voir le projet

 2

 TERMINÉ 

Research Training Network on Integrated Component Cycling in Epithelial Cell Motility (InCeM)

Date du début: 1 janv. 2015, Date de fin: 31 déc. 2018,

Cell migration (cell motility) is a fundamental biological process that is pivotal in (i) tissue formation and repair (health) and (ii) tissue invasion during carcinogenesis (disease). Understanding and controlling cell migration will have major clinical impact. Clarifying mechanisms driving cell motility has been challenging due to the complex underlying cellular mechanisms; these involve multipl ...
Voir le projet

 11

 TERMINÉ 

PERSONALIZED ENGINE FOR CANCER INTEGRATIVE STUDY AND EVALUATION (PrECISE)

Date du début: 1 janv. 2016, Date de fin: 31 déc. 2018,

Despite of their great promise, high-throughput technologies in cancer research have often failed to translate to major therapeutic advances in the clinic. One challenge has been tumour heterogeneity, where multiple competing subclones coexist within a single tumour. Genomic heterogeneity renders it difficult to identify all driving molecular alterations, and thus results in therapies that only ta ...
Voir le projet

 10

 TERMINÉ 

A dedicated trimodality (PET/MR/EEG) imaging tool for schizophrenia (TRIMAGE)

Date du début: 1 déc. 2013, Date de fin: 30 nov. 2018,

"Schizophrenia is a severe mental disorder that manifests early in life and imposes a high social and economic burden on European societies. An imaging tool that enables the diagnosis of schizophrenia during early development is extremely desirable and is requested by the clinical community in order to make the management of the disease more effective.TRIMAGE aims to optimise and validate an integ ...
Voir le projet

 11

 TERMINÉ 

Human Brain Project Specific Grant Agreement 1 (HBP SGA1)

Date du début: 1 avr. 2016, Date de fin: 31 mars 2018,

Understanding the human brain is one of the greatest scientific challenges of our time. Such an understanding can provide profound insights into our humanity, leading to fundamentally new computing technologies, and transforming the diagnosis and treatment of brain disorders. Modern ICT brings this prospect within reach. The HBP Flagship Initiative (HBP) thus proposes a unique strategy that uses I ...
Voir le projet

 126

 TERMINÉ 

Counteracting psychosis by optimizing interaction (INTERACT)

Date du début: 1 avr. 2013, Date de fin: 31 mars 2018,

Psychotic disorders are amongst the most severe mental disorders. However, current treatments have failed to reduce disability or change the prospects for recovery for patients with a psychotic disorder. In this project, I will investigate an entirely novel therapy, targeting the core vulnerability profile of altered person-environment interactions underlying psychosis, specifically increased stre ...
Voir le projet

 3

 TERMINÉ 

Neurobiology and Treatment of Adolescent Female Conduct Disorder: The Central Role of Emotion Processing (FEMNAT-CD)

Date du début: 1 sept. 2013, Date de fin: 28 févr. 2018,

Conduct Disorder (CD) and Oppositional Defiant Disorder with symptoms of Conduct Disorder (which is included among the abbreviation “CD” throughout the proposal) has a highly negative impact for the affected individual as well as for families and society. Although the number of females exhibiting serious aggressive behaviours is growing, the majority of studies on aetiology and treatment of CD hav ...
Voir le projet

 19

 TERMINÉ 

Neoadjuvant Nanomedicines for vascular Normalization (NeoNaNo)

Date du début: 1 janv. 2013, Date de fin: 31 déc. 2017,

The aim of my proposal is to establish ‘Neoadjuvant Nanomedicines for vascular Normalization’ (NeoNaNo) as a novel concept for improving the efficacy of combined modality anticancer therapy. This concept is radically different from all other drug targeting approaches evaluated to date, since nanomedicines are not used to directly improve drug delivery to tumors, but to normalize the tumor vasculat ...
Voir le projet

 1

 TERMINÉ 

Systems medicine of chronic inflammatory bowel disease (SYSMEDIBD)

Date du début: 1 déc. 2012, Date de fin: 30 nov. 2017,

Inflammatory bowel disease (IBD) is a major health problem with severe co-morbidities, requiring life-long treatment. Oscillating processes, like biological clocks are well studied and modeled in a number of systems. Circadian rhythms are extremely important for optimal treatments of patients. Recently, the NfkB pathway has been shown to be oscillating. In this project, we will model NfkB oscillat ...
Voir le projet

 13

 TERMINÉ 

Novel Diagnostics and Biomarkers for Early Identification of Chronic Inflammatory Joint Diseases (D-BOARD)

Date du début: 1 oct. 2012, Date de fin: 30 sept. 2017,

"Chronic inflammatory diseases of joints are major causes of disability in the ageing population. Osteoarthritis (OA) is one of the most common types of arthritis and a major cause of pain and disability in older individuals. OA is expected to place a heavy burden on European healthcare systems, as European citizens grow older. Cartilage damage in OA is detected radiographically by decreases in jo ...
Voir le projet

 15

 TERMINÉ 

Clinical and system –omics for the identification of the MOlecular DEterminants of established Chronic Kidney Disease (iMODE-CKD)

Date du début: 1 sept. 2013, Date de fin: 31 août 2017,

iMODE-CKD integrates multi-disciplinary expertise in proteomics, metabolomics, transcriptomics, bioinformatics, pathology, and clinical science from leading academic and industrial investigators, establishing a unique training platform on biomarker research and Systems Biology. Special emphasis is placed on the application of a wide range of –omics and bioinformatics techniques to clinical researc ...
Voir le projet

 10

 TERMINÉ 

Companion Nanodiagnostics for Quantifying EPR and Stratifying Patients to Targeted Nanotherapies (CONQUEST)

Date du début: 1 janv. 2016, Date de fin: 30 juin 2017,

CONQUEST aims to commercialise a first-of-its-kind platform technology for imaging a biological effect – i.e. the EPR effect – that is predictive for a cancer patient's response to tumor-targeted nanomedicine (NM) therapy. CONQUEST thereby addresses a key issue in the (nano)pharmaceutical industry; as currently large proportions of cancer patients do not respond to NM, while others show major impr ...
Voir le projet

 1

 TERMINÉ 

Chronotherapeutic lifestyle intervention for diabetes and obesity to reset the circadian rhythm and improve cardiometabolic risk in the European working population (EURHYTHDIA)

Date du début: 1 oct. 2011, Date de fin: 30 juin 2017,

Modern lifestyle has dramatically changed the daily rhythms of life. Physical activity, diet and light exposure are no longer restricted to daytime hours, as technical and economical de-mands fuel the necessity to work outside usual working hours. Recent studies show that al-tered light exposure, shifted exercise patterns and untimely food intake following extended active periods into the night di ...
Voir le projet

 17

 TERMINÉ 

Integrated DEsign and AnaLysis of small population group trials (IDEAL)

Date du début: 1 nov. 2013, Date de fin: 30 avr. 2017,

There exist more than 7000 rare diseases worldwide and the European Society of Paediatric Oncology stated that 75% of rare diseases affect children and 30% of rare disease patients die before the age of five. Usual statistical methods for proving efficacy and safety of therapies fail to provide cost-efficient and reliable results in small populations. There is a pressing need to integrate a broad ...
Voir le projet

 10

 TERMINÉ 

Towards Tissue Engineering Solutions for Cardiovascular Surgery (TECAS)

Date du début: 1 janv. 2013, Date de fin: 31 déc. 2016,

"The aim of the TECAS ITN is to integrate the major European contributors in the field of cardiovascular tissue engineering (TE) and regenerative medicine (RM), to generate a coherent framework of expertise which will facilitate the training and career development of early stage researchers (ESRs) in the field. In particular, the intention of this ITN is to focus on the clinical needs of cardiac v ...
Voir le projet

 7

 TERMINÉ 

Telemonitoring and Telemedicine for Hospitals Assisted by ICT for Life saving co-morbid patients in Europe As part of a Patient personalised care program of the EU (THALEA)

Date du début: 1 nov. 2013, Date de fin: 31 oct. 2016,

A growing body of evidence suggests outcome improvement in Intensive Care Unit (ICU) patients by means of telemedicine. At present a highly interoperable, manufacturer-independent telemedicine-platform for detection of ICU-patients at increased risk is missing. Encouraging results in other eHealth-projects influenced the decision to use pre-commercial procurement (PCP), in order to provide best p ...
Voir le projet

 8

 TERMINÉ 

Transposon-based, targeted ex vivo gene therapy to treat age-related macular degeneration (AMD) (TARGETAMD)

Date du début: 1 nov. 2012, Date de fin: 31 oct. 2016,

Age-related Macular Degeneration (AMD), a neurodegenerative disease of the retina, is a major cause of blindness in elderly people. Due to the aging population, AMD has been referred to as a “time bomb” in society. In the exudative form of AMD, high levels of vascular endothelial cell growth factor (VEGF) and low levels of pigment-epithelial derived factor (PEDF), an inhibitor of vascularization a ...
Voir le projet

 16

 TERMINÉ 

Regional Anaesthesia Simulator and Assistant (RASimAs)

Date du début: 1 nov. 2013, Date de fin: 31 oct. 2016,

Description RASimAs: Simulating anaesthesia outcomeA better outlook for those about to undergo surgery or have a child: The RASimAs project is working on a virtual reality simulator for doctors who are performing regional (or spinal) anaesthesia. This tool supports prediction and avoidance of possible complications during regional anaesth ...
Voir le projet

 11

 TERMINÉ 

The Human Brain Project (HBP)

Date du début: 1 oct. 2013, Date de fin: 30 sept. 2016,

Understanding the human brain is one of the greatest challenges facing 21st century science. If we can rise to the challenge, we can gain profound insights into what makes us human, develop new treatments for brain diseases and build revolutionary new computing technologies. Today, for the first time, modern ICT has brought these goals within sight. The goal of the Human Brain Project, part of the ...
Voir le projet

 116

 TERMINÉ 

A Gateway to European Kidney Research Resources - KidneyConnect (KidneyConnect)

Date du début: 1 août 2013, Date de fin: 31 juil. 2016,

Diabetes, Cardiovascular and Chronic kidney (DCC) -diseases are relentlessly increasing globally, causing enormous human suffering, premature deaths and unsustainable costs. Leading European research has indisputably pointed that the kidney filtration barrier and its epithelial cell, the podocyte, is a common denominator for the DCC-diseases. However, European excellence and expertise have remaine ...
Voir le projet

 19

 TERMINÉ 

Markers for Sub-Clinical Cardiovascular Risk Assessemnt (EU-MASCARA)

Date du début: 1 déc. 2011, Date de fin: 31 mai 2016,

EU-MASCARA is a collaborative project that aims to improve diagnosis of cardiovascular diseases and prediction of cardiovascular risk by analysing a panel of biomarkers. EU-MASCARA aims to examine genetic, proteomic and metabolomic markers together with markers of inflammation, oxidative stress and cardiac remodelling to study their incremental diagnostic and predictive value over and above existi ...
Voir le projet

 16

 TERMINÉ 

Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE)

Date du début: 1 nov. 2010, Date de fin: 30 avr. 2016,

Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders in children, affecting approximately 5% children in Europe. Methylphenidate (MPH) is the most-commonly prescribed medication for ADHD children; it is also increasingly used in ADHD adults. In 2007, the European Commission requested a referral to the Committee for Medicinal Products for Human Use ...
Voir le projet

 17

 TERMINÉ 

Structure-Function Analysis of the Chemokine Interactome for Therapeutic Targeting and Imaging in Atherosclerosis (ATHEROPROTECT)

Date du début: 1 avr. 2010, Date de fin: 31 mars 2016,

Atherosclerosis is characterized by chronic inflammation of the arterial wall. Mononuclear cell recruitment is driven by chemokines that can be deposited e.g. by activated platelets on inflamed endothelium. Chemokines require oligomerization and immobilization for efficient function, and recent evidence supports the notion that heterodimer formation between chemokines constitutes a new regulatory ...
Voir le projet

 2

 TERMINÉ 

SAFER AND FASTER EVIDENCE-BASED TRANSLATION (SAFE-T)

Date du début: 15 juin 2009, Date de fin: 14 juin 2015,

The public-private consortium composed of complementary SMEs, academic and clinical centers of excellence and EMEA as partner proposes SAFE-T (Safer And Easter Evidence-based Iranslation) project for the establishment of a biomarker (BM) qualification process and its validation in clinical biomarker studies designed for the translation, performance testing and eventual regulatory qualifIcatIon of ...
Voir le projet

 26

 TERMINÉ 

European Friedreich's Ataxia Consortium for Translational Studies (EFACTS)

Date du début: 1 mai 2010, Date de fin: 30 avr. 2015,

EFACTS (the European Friedreich’s Ataxia Consortium for Translational Studies) assembles a body of expertise to adopt a translational research strategy for the rare autosomal recessive neurological disease, Friedreich’s ataxia (FRDA). FRDA is a severely debilitating disease that leads to loss of the ability to walk and dependency for all activities. Some patients have cardiomyopathy that can cause ...
Voir le projet

 15

 TERMINÉ 

THERAPEUTIC AND PREVENTIVE IMPACT OF NUTRITIONAL LIPIDS ON NEURONAL AND COGNITIVE PERFORMANCE IN AGING, ALZHEIMER’S DISEASE AND VASCULAR DEMENTIA (LIPIDIDIET)

Date du début: 1 août 2008, Date de fin: 31 mars 2015,

Major objective: It is our aim to develop a lipid based diet that is able to delay or prevent onset of Alzheimer’s disease and related diseases and has a stabilizing effect on cognitive performance in aging. Multiple lines of evidence suggest that there is a large overlap between risk factor of these three diseases. Importantly, there is equally strong evidence that prevention and treatment of the ...
Voir le projet

 19

 TERMINÉ 

Brain-inspired multiscale computation in neuromorphic hybrid systems (BrainScaleS)

Date du début: 1 janv. 2011, Date de fin: 31 mars 2015,

The BrainScaleS project aims at understanding function and interaction of multiple spatial and temporal scales in brain information processing. The fundamentally new approach of BrainScaelS lies in the in-vivo biological experimentation and computational analysis. Spatial scales range from individual neurons over larger neuron populations to entire functional brain areas. Temporal scales range fro ...
Voir le projet

 17

 TERMINÉ 

Development & Evaluation of a Viable Stent Device for the Treatment of BronchoTracheal Cancer (PULMOSTENT)

Date du début: 1 avr. 2012, Date de fin: 31 mars 2015,

Lung cancer is the most common cancer in terms of both incidence and mortality, worldwide. With a median age at diagnosis of 71, lung cancer is mainly affecting the aging population. Airway stenosis is a key problem with significant morbidity and premature death. Endobronchial stenting is a proven therapy to keep the airways open. Nevertheless the currently used clinical stents have major disadvan ...
Voir le projet

 8

 TERMINÉ 

SUB nanosecond Leverage In PET/MR ImAging (SUBLIMA)

Date du début: 1 sept. 2010, Date de fin: 28 févr. 2015,

The SUBLIMA project aims at truly simultaneous, fully integrated, solid-state PET/MR technology for concurrent functional and anatomical imaging with unsurpassed image quality. It will combine the extremely sensitive functional imaging possibilities provided by PET with the excellent soft-tissue contrast and complementary functional imaging capabilities of MR. For the first time, time-of-flight (T ...
Voir le projet

 14

 TERMINÉ 

Systems biology towards novel chronic kidney disease diagnosis and treatment (SysKID)

Date du début: 1 janv. 2010, Date de fin: 31 déc. 2014,

Chronic kidney disease (CKD) affects up to 10% of the population. Besides eventual progression towards end stage renal disease CKD impacts the patient’s quality of life by causing serious comorbidities including cardiovascular complications and bone metabolism disorders. On the everyday clinical level early stage diagnosis and tailored treatment of CKD are still inadequate. In addition, CKD seems ...
Voir le projet

 30

 TERMINÉ 

Warehousing images in the digital hospital (WIDTH): interpretation, infrastructure, and integration (WIDTH)

Date du début: 16 mai 2011, Date de fin: 15 déc. 2014,

Advanced information communications technology (ICT) has created an expectation that the innovative use of ICT can deliver high quality healthcare to a situation where patients’ data can be supplied seamlessly to support clinical decisions. The world however has moved beyond the current reactive model and hamstrung by the problems of fragmentation and lack of coordination. Medical images are of a ...
Voir le projet

 7

 TERMINÉ 

Access to Opioid Medication in Europe (ATOME)

Date du début: 1 déc. 2009, Date de fin: 30 nov. 2014,

"Medicines derived from opium are very valuable in medicine practice & therefore regarded as essential medicines. However, they are generally not readily available for patients who are in need of them for medical reasons. It is estimated that over 80% of the world's population is inadequately treated, because opioid (pain relieving) medicines have been categorized as ""controlled substances"", du ...
Voir le projet

 11

 TERMINÉ 

The Function of inflammatory signalling pathways in acute and chronic liver disease and liver cancer (LUEDDE-MED3-AACHEN)

Date du début: 1 sept. 2008, Date de fin: 31 août 2014,

The aim of this proposal is to examine the role of inflammatory signalling pathways in murine models of liver and biliary disease by application of conditional gene targeting using cre/loxP technology. Previous studies have provided evidence that the NF-kB pathway and its activating kinase complex – consisting of three subunits: IKK1, IKK2 and NEMO – are crucial regulators of liver physiology and ...
Voir le projet

 1

 TERMINÉ 

Platform for Large Area Conformable Electronics by InTegration (PLACE-it)

Date du début: 1 févr. 2010, Date de fin: 30 nov. 2013,

In the PLACE-it project flexible large area electronics technologies such as foil-based electronics and light sources, stretchable and fabric electronics are combined to generate conformable systems with unique properties and technical performance. This is done by analysing, developing and implementing technology for the proper combination of functionalities in foil, stretchable and fabric substr ...
Voir le projet

 16